Detalhe da pesquisa
1.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis
; 76(3): e526-e529, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737946
2.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med
; 387(3): 275-277, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767428
3.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214224
4.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
medRxiv
; 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262089
5.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
medRxiv
; 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262094